Literature DB >> 28148786

Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion.

Judith M Phillips1, Tom Gallagher2, Susan R Weiss3.   

Abstract

The coronavirus (CoV) S protein requires cleavage by host cell proteases to mediate virus-cell and cell-cell fusion. Many strains of the murine coronavirus mouse hepatitis virus (MHV) have distinct, S-dependent organ and tissue tropisms despite using a common receptor, suggesting that they employ different cellular proteases for fusion. In support of this hypothesis, we found that inhibition of endosomal acidification only modestly decreased entry, and overexpression of the cell surface protease TMPRSS2 greatly enhanced entry, of the highly neurovirulent MHV strain JHM.SD relative to their effects on the reference strain, A59. However, TMPRSS2 overexpression decreased MHV structural protein expression, release of infectious particles, and syncytium formation, and endogenous serine protease activity did not contribute greatly to infection. We therefore investigated the importance of other classes of cellular proteases and found that inhibition of matrix metalloproteinase (MMP)- and a disintegrin and metalloprotease (ADAM)-family zinc metalloproteases markedly decreased both entry and cell-cell fusion. Suppression of virus by metalloprotease inhibition varied among tested cell lines and MHV S proteins, suggesting a role for metalloprotease use in strain-dependent tropism. We conclude that zinc metalloproteases must be considered potential contributors to coronavirus fusion.IMPORTANCE The family Coronaviridae includes viruses that cause two emerging diseases of humans, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), as well as a number of important animal pathogens. Because coronaviruses depend on host protease-mediated cleavage of their S proteins for entry, a number of protease inhibitors have been proposed as antiviral agents. However, it is unclear which proteases mediate in vivo infection. For example, SARS-CoV infection of cultured cells depends on endosomal acid pH-dependent proteases rather than on the cell surface acid pH-independent serine protease TMPRSS2, but Zhou et al. (Antiviral Res 116:76-84, 2015, doi:10.1016/j.antiviral.2015.01.011) found that a serine protease inhibitor was more protective than a cathepsin inhibitor in SARS-CoV-infected mice. This paper explores the contributions of endosomal acidification and various proteases to coronavirus infection and identifies an unexpected class of proteases, the matrix metalloproteinase and ADAM families, as potential targets for anticoronavirus therapy.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  TMPRSS2; coronavirus; membrane fusion; metalloprotease; virus entry

Mesh:

Substances:

Year:  2017        PMID: 28148786      PMCID: PMC5375694          DOI: 10.1128/JVI.01564-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion.

Authors:  Susan T Hingley; Isabelle Leparc-Goffart; Su-Hun Seo; Jean C Tsai; Susan R Weiss
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

2.  Role of proteases in the release of porcine epidemic diarrhea virus from infected cells.

Authors:  Kazuya Shirato; Shutoku Matsuyama; Makoto Ujike; Fumihiro Taguchi
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

3.  Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence.

Authors:  J J Phillips; M M Chua; E Lavi; S R Weiss
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.

Authors:  Ilona Glowacka; Stephanie Bertram; Marcel A Müller; Paul Allen; Elizabeth Soilleux; Susanne Pfefferle; Imke Steffen; Theodros Solomon Tsegaye; Yuxian He; Kerstin Gnirss; Daniela Niemeyer; Heike Schneider; Christian Drosten; Stefan Pöhlmann
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

5.  Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.

Authors:  Miyuki Kawase; Kazuya Shirato; Lia van der Hoek; Fumihiro Taguchi; Shutoku Matsuyama
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

6.  A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry.

Authors:  Ana Shulla; Taylor Heald-Sargent; Gitanjali Subramanya; Jincun Zhao; Stanley Perlman; Tom Gallagher
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

Review 7.  Mechanisms of coronavirus cell entry mediated by the viral spike protein.

Authors:  Sandrine Belouzard; Jean K Millet; Beth N Licitra; Gary R Whittaker
Journal:  Viruses       Date:  2012-06-20       Impact factor: 5.048

Review 8.  Novel insights into proteolytic cleavage of influenza virus hemagglutinin.

Authors:  Stephanie Bertram; Ilona Glowacka; Imke Steffen; Annika Kühl; Stefan Pöhlmann
Journal:  Rev Med Virol       Date:  2010-09       Impact factor: 6.989

9.  TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.

Authors:  Shiori Haga; Noriyo Nagata; Tadashi Okamura; Norio Yamamoto; Tetsutaro Sata; Naoki Yamamoto; Takehiko Sasazuki; Yukihito Ishizaka
Journal:  Antiviral Res       Date:  2009-12-06       Impact factor: 5.970

10.  SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.

Authors:  I-Chueh Huang; Berend Jan Bosch; Fang Li; Wenhui Li; Kyoung Hoa Lee; Sorina Ghiran; Natalya Vasilieva; Terence S Dermody; Stephen C Harrison; Philip R Dormitzer; Michael Farzan; Peter J M Rottier; Hyeryun Choe
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

View more
  29 in total

1.  Identification of H209 as Essential for pH 8-Triggered Receptor-Independent Syncytium Formation by S Protein of Mouse Hepatitis Virus A59.

Authors:  Pei Li; Yiwei Shan; Wangliang Zheng; Xiuyuan Ou; Dan Mi; Zhixia Mu; Kathryn V Holmes; Zhaohui Qian
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

2.  Porcine deltacoronavirus enters cells via two pathways: A protease-mediated one at the cell surface and another facilitated by cathepsins in the endosome.

Authors:  Jialin Zhang; Jianfei Chen; Da Shi; Hongyan Shi; Xin Zhang; Jianbo Liu; Liyan Cao; Xiangdong Zhu; Ye Liu; Xiaobo Wang; Zhaoyang Ji; Li Feng
Journal:  J Biol Chem       Date:  2019-05-08       Impact factor: 5.157

3.  Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial.

Authors:  Reaz Mahmud; Md Mujibur Rahman; Iftikher Alam; Kazi Gias Uddin Ahmed; A K M Humayon Kabir; S K Jakaria Been Sayeed; Mohammad Aftab Rassel; Farhana Binte Monayem; Md Shahidul Islam; Mohammad Monirul Islam; Anindita Das Barshan; Mohammad Mahfuzul Hoque; Md Uzzal Mallik; Mohammad Abdullah Yusuf; Mohammad Zaid Hossain
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  Doxycycline as a potential partner of COVID-19 therapies.

Authors:  Alexandre E Malek; Bruno P Granwehr; Dimitrios P Kontoyiannis
Journal:  IDCases       Date:  2020-06-06

5.  Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.

Authors:  Alain Le Coupanec; Marc Desforges; Benedikt Kaufer; Philippe Dubeau; Marceline Côté; Pierre J Talbot
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

Review 6.  Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.

Authors:  Miguel Angel Casillas Santana; Juan Antonio Arreguín Cano; Alejandro Dib Kanán; Farid Alonso Dipp Velázquez; Paulina Del Carmen Sosa Munguía; Gabriel Alejandro Martínez Castañón; Brenda Eréndida Castillo Silva; Carolina Sámano Valencia; Marco Felipe Salas Orozco
Journal:  Medicina (Kaunas)       Date:  2021-05-13       Impact factor: 2.430

Review 7.  COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.

Authors:  Joowon Yim; Hee Hyun Lim; Youngjoo Kwon
Journal:  Arch Pharm Res       Date:  2021-05-28       Impact factor: 6.010

8.  Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19.

Authors:  Shengjie Shi; Min Su; Ge Shen; Yan Hu; Fan Yi; Ziyan Zeng; Pan Zhu; Gang Yang; Hui Zhou; Qiong Li; Xiaobing Xie
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 20.693

Review 9.  Targeting zinc metalloenzymes in coronavirus disease 2019.

Authors:  Urszula Doboszewska; Piotr Wlaź; Gabriel Nowak; Katarzyna Młyniec
Journal:  Br J Pharmacol       Date:  2020-08-17       Impact factor: 8.739

Review 10.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.